Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies

TT Lai, B Gericke, M Feja, M Conoscenti… - npj Parkinson's …, 2023 - nature.com
Synucleinopathies are neurodegenerative disorders characterized by alpha-synuclein
(αSyn) accumulation in neurons or glial cells, including Parkinson's disease (PD), dementia …

Parkinson's disease: exploring different animal model systems

E Khan, I Hasan, ME Haque - International journal of molecular sciences, 2023 - mdpi.com
Disease modeling in non-human subjects is an essential part of any clinical research. To
gain proper understanding of the etiology and pathophysiology of any disease, experimental …

Targeted activation of midbrain neurons restores locomotor function in mouse models of parkinsonism

D Masini, O Kiehn - Nature communications, 2022 - nature.com
The pedunculopontine nucleus (PPN) is a locomotor command area containing
glutamatergic neurons that control locomotor initiation and maintenance. These motor …

Unilateral intrastriatal 6-hydroxydopamine lesion in mice: a closer look into non-motor phenotype and glial response

B Mendes-Pinheiro, C Soares-Cunha, A Marote… - International Journal of …, 2021 - mdpi.com
Parkinson's disease (PD) is a prevalent movement disorder characterized by the
progressive loss of dopaminergic neurons in substantia nigra pars compacta (SNpc). The 6 …

[HTML][HTML] A mouse model of sleep disorders in Parkinson's disease showing distinct effects of dopamine D2-like receptor activation

D de Castro Medeiros, C Plewnia, RV Mendes… - Progress in …, 2023 - Elsevier
Excessive daytime sleepiness (EDS) and sleep fragmentation are often observed in
Parkinson's disease (PD) patients and are poorly understood despite their considerable …

Targeting mitochondria with small molecules: A promising strategy for combating Parkinson's disease

C Pal - Mitochondrion, 2024 - Elsevier
Abstract Parkinson's disease (PD), a neurodegenerative disorder, is one of the most
significant challenges confronting modern societies, affecting millions of patients globally …

Neuroprotective effects of microRNA 124 in Parkinson's disease mice

F Zhang, Y Yao, N Miao, N Wang, X Xu… - Archives of Gerontology …, 2022 - Elsevier
Background: Recent studies have revealed the close correlation between microRNAs
(miRs) and Parkinson's disease (PD). Here, we aimed to investigate the neuroprotective …

ARL6IP5 ameliorates α-synuclein burden by inducing autophagy via preventing ubiquitination and degradation of ATG12

I Siddique, K Kamble, S Gupta, K Solanki… - International Journal of …, 2023 - mdpi.com
Recent advanced studies in neurodegenerative diseases have revealed several links
connecting autophagy and neurodegeneration. Autophagy is the major cellular degradation …

Serotonergic and dopaminergic neurons in the dorsal raphe are differentially altered in a mouse model for parkinsonism

L Boi, Y Johansson, R Tonini, R Moratalla, G Fisone… - ELife, 2024 - elifesciences.org
Parkinson's disease (PD) is characterized by motor impairments caused by degeneration of
dopamine neurons in the substantia nigra pars compacta. In addition to these symptoms, PD …

The 6-hydroxydopamine rat model of Parkinson's disease

RP Guimarães, DL Ribeiro, KB Dos Santos… - JoVE (Journal of …, 2021 - jove.com
Motor symptoms of Parkinson's disease (PD)-bradykinesia, akinesia, and tremor at rest-are
consequences of the neurodegeneration of dopaminergic neurons in the substantia nigra …